Can a daily dose of 300 mg phenytoin cause skin rash?

Yes, phenytoin 300mg daily can cause skin rashes

Phenytoin at any dose, including 300mg daily, is well-documented to cause skin rashes, and you must discontinue the drug immediately if a rash appears. 1

Incidence and Risk

The FDA label explicitly warns that skin rash is a recognized adverse reaction to phenytoin, and patients must be instructed to call their physician if skin rash develops 1. The incidence is substantial:

• 19.4% of patients developed cutaneous reactions in one study of head-injured patients receiving phenytoin for seizure prophylaxis 2
• Rashes typically appear between Day 5 through Day 91 of therapy, though most occur within the first few weeks 2
• Black patients may have an increased (though still rare) risk of hypersensitivity reactions including skin rash 1

Types of Rashes

Phenytoin can cause a spectrum of dermatologic reactions ranging from mild to life-threatening:

Mild reactions:

• Morbilliform (measles-like) rash - most common 1
• Scarlatiniform rash 1
• Maculopapular eruptions 3

Severe reactions:

• Stevens-Johnson syndrome (SJS) 1
• Toxic epidermal necrolysis (TEN) 1
• Exfoliative dermatitis 1
• Bullous or purpuric dermatitis 1
• DRESS syndrome (Drug Rash with Eosinophilia and Systemic Symptoms) 4, 5, 6

Critical Management Algorithm

If any rash appears:

1. Discontinue phenytoin immediately 1
2. Assess rash severity:

For exfoliative, purpuric, bullous rashes OR suspected SJS/TEN/lupus:

• Never resume phenytoin - this is an absolute contraindication 1
• Consider alternative anticonvulsant therapy
• Provide supportive care; severe cases may require corticosteroids or IVIG 4

For mild morbilliform/scarlatiniform rashes:

• Wait until rash completely disappears
• May cautiously attempt to resume therapy
• If rash recurs, phenytoin is permanently contraindicated 1

Important Caveats

DRESS syndrome warning: This potentially fatal hypersensitivity reaction presents with fever, rash, lymphadenopathy, and visceral organ involvement (especially hepatitis). It has approximately 10% mortality, primarily from fulminant liver failure 6. One case report documented DRESS developing in a patient on 300mg daily phenytoin 4. Watch for:

• Fever with rash
• Lymphadenopathy
• Eosinophilia (patients with cutaneous reactions had significantly higher eosinophil counts) 2
• Elevated liver enzymes

Rate of administration matters: One case demonstrated that rapid IV infusion (60mg/minute vs recommended 50mg/minute) may increase risk of severe bullous reactions 7, though this patient was receiving loading doses rather than maintenance therapy.

Cross-reactivity: Exercise caution with structurally similar compounds (barbiturates, succinimides, oxazolidinediones) in patients who developed phenytoin hypersensitivity 1.

The dose of 300mg daily is irrelevant to hypersensitivity reactions - these are non-dose-dependent reactions that can occur at any therapeutic dose 2. The key is vigilant monitoring, especially in the first 3 months of therapy, and immediate discontinuation if rash develops.